Environmental & Analytical Toxicology

Roberts J

Publications

• Research Article
  Micropollutant Point Sources in the Built Environment: Identification and Monitoring of Priority Pharmaceutical Substances in Hospital Effluents
  Author(s): Helwig K, Hunter C, MacLachlan J, McNaughtan M, Roberts J, Cornelissen A, Dagot C, Evenblij H, Klepiszewski K, Lyko S, Nafo I, McArdell CS, Venditti S and Pahl OHelwig K, Hunter C, MacLachlan J, McNaughtan M, Roberts J, Cornelissen A, Dagot C, Evenblij H, Klepiszewski K, Lyko S, Nafo I, McArdell CS, Venditti S and Pahl O
  
  A method is described for the identification of priority micropollutants (pharmaceuticals) in the aquatic environment originating from hospitals. The lack of data on the range and volume of prescribed pharmaceuticals, and on their behaviour in the environment, presented a considerable challenge to the initial selection process. The final selection of pharmaceutical substances to be included in the monitoring campaigns was based on literature data, existing priority lists, national consumption patterns and expert input from within the regions (Northwest Europe). Fifteen micropollutant compounds were identified from the diverse range of reported and prescribed pharmaceuticals in the healthcare sector:atenolol, carbamazepine, diclofenac, naproxen, lidocaine, ifosphamide, cyclophosphamide, ciprofloxacin, erythromycin, clarithromycin, sulfamethoxazole, iopromide, iopamidol, diatrizoate, an.. Read More»
  DOI: 10.4172/2161-0525.1000177

  Abstract PDF